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Isocitrate dehydrogenase from Escherichia coli is regulated by a reversible phosphorylation mechanism. 
We report here the amino acid sequence round the phosphorylation site; this is the first such sequence to
be reported for a bacterial protein kinase. The sequence does not resemble sequences phosphorylated by
cyclic AMP-dependent protein kinase. 
Isocitrate dehydrogenase Protein phosphorylation 
1. INTRODUCTION 
The NADP-linked isocitrate dehydrogenase (EC 
1.1.1.42) of Escherichia coli can be regulated by 
reversible phosphorylation [1,2]: this is the first ex- 
ample of control of a key metabolic enzyme by 
phosphorylation in a prokaryote (review [3]). The 
phosphorylation and dephosphorylation of 
isocitrate dehydrogenase are mediated by a single 
bifunctional enzyme, isocitrate dehydrogenase 
kinase/phosphatase, and cause inactivation and 
activation, respectively [4-61. The metabolic role 
of the phosphorylation system is to resolve the 
competition between isocitrate dehydrogenase and 
the glyoxylate bypass enzyme isocitrate lyase that 
occurs during growth on acetate (review [3]). 
The only phosphoamino acid present in 
phosphorylated isocitrate dehydrogenase is a 
phosphoserine residue [2,5,7]. We have shown 
that, either in vivo or in vitro, the enzyme is 
phosphorylated at a single site contained within a 
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unique 22-residue chymotryptic peptide [7]. To 
compare the specificity of isocitrate dehydrogenase 
kinase with those of other protein kinases we have 
subjected this peptide to automated sequence 
analysis. We now report the sequence of the first 
14 residues of the chymotryptic peptide, including 
the phosphoserine residue. 
2. EXPERIMENTAL 
2.1. Materials 
The active form of isocitrate dehydrogenase was 
purified from E. coli ML308 [8] and 
phosphorylated using isocitrate dehydrogenase 
kinase/phosphatase and [y-32P]ATP [5]. The 
material was carboxymethylated and digested with 
chymotrypsin and the 32P-containing chymotryptic 
peptide was isolated as in [7]. Thermolysin was ob- 
tained from Boehringer (Lewes, England). The 
materials for automated sequence analysis were 
obtained as in [9, lo]. The sources of other 
materials were as given in [5,7,8]. 
2.2. Automated sequence analysis 
This was carried out as in [9,10] using a 
Beckman 890C sequencer. The peptides were ap- 
plied to the sequencer cup containing Polybrene 
[9,11]. Conversion to Pth-amino acids was carried 
out as described in the text. 
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2.3. Identification of Pth-amino acids and amino 
acid analysis 
The Pth-amino acids were identified by 
reversed-phase HPLC as in [9,12]. Samples were 
hydrolysed in 5.5 N HI and subjected to amino 
acid analysis on an LKB Biochrom 4400 analyser. 
2.4. Sub-digestion with thermolysin 
The 32P-containing ch~otrypti~ peptide 
(10 nmol) was incubated with 40 pg thermolysin in 
0.1% ammonium bicarbonate containing 1 mM 
CaCl2 for 16 h at 37°C. The material was freeze- 
dried, dissolved in 0.1% trifluoroacetic acid and 
applied to a Waters Crs pbondapak reversed phase 
column (30 cm x 3.9 mm). Peptides were eluted 
with a linear gradient of lo-35% acetonitrile in 
0.1% trifluoroacetic acid (0.5% acetonitrile/min, 
flow rate 0.5 ml/min) and detected by absorbance 
measurements at 215 nm. 
3. RESULTS AND DISCUSSION 
Amino acid analysis of the 22-residue 
chymotryptic phosphopeptide from isocitrate 
dehydrogenase revealed that it contained only one 
serine residue [7]. The peptide was subjected to se- 
quence analysis on a Beckman 890C sequencer. In 
the first experiment the Pth-amino acids were 
generated by treatment with 0.1 M HCl for 10 min 
at 80°C [9], and were detected and quantitated 
after HPLC by absorbance measurements at 
254 nm. The first 14 residues were assigned suc- 
cessfully with the exception of residue 10 (table 1). 
No Pth-amino acid was detected at this turn. 
However, a peak of 32P radioactivity was released 
at this turn (table l), suggesting that residue 10 is 
the phosphoserine residue. The trail of 32P at 
subsequent urns is probably caused by poor ex- 
traction of Pi from the sequencer cup. The provi- 
sional assignment of phosphoserine at residue 10 is 
consistent with the failure to detect a Pth-amino 
acid at this turn because Pth-phosphoserine breaks 
down readily to give Pth-dehydroserine, which 
does not absorb significantly at 254 nm, The low 
yields of threonine at turns 1 and 2 in this experi- 
ment were caused by the relatively harsh condi- 
tions used for the generation of the Pth-amino 
acids [9]. 
In a second experiment, the Pth-amino acids 
were generated by treatment with 20% 
Table 1 
Sequence analysis of chymotryptic phosphopeptide 
Residue Pth-amino Recovery “P re- Amino acid 
no. acid (nmol) leased from back- 
&pm) hydrolysis 
1 Thr 7.7 980 Thr 
2 Thr 5.5 0 Thr 
3 Pro 31.7 26 Pro 
4 Val 20.4 0 Val 
5 Gly 21.5 4 Gly 
6 Gly 20.1 0 Gly 
7 Gly 22.4 0 Gly 
8 IIe - 0 Ile 
9 Arg 23.2 79 Arg 
10 - - 493 - 
11 Leu 13.1 332 Leu 
12 Asn 10.3 276 Asn 
13 Val 3.0 205 - 
14 Ala 0.8 25 - 
Sequencing of the peptide (50 nmol, 450000 cpm) and 
analysis and quantitation of the Pth-derivatives were as 
in [9]. The total 32P released at each turn was calculated 
by liquid scintillation counting. The remainder of each 
Pth-derivative was subjected to back-hydrolysis and 
amino acid anaiysis: threonine was detected as CY- 
~inobutyric acid 
trifluoroacetic acid for 8 min at 80°C; when serine 
or threonine residues were expected treatment was 
for 10 min at 60°C [l 11. The HPLC effluents were 
monitored at both 254 and 313 nm [ 1 l] to allow 
detection of the dehydro derivatives of serine and 
threonine. The first 8 turns confirmed the 
assignments made in the first sequencer run. 
However, the 3 glycine residues at positions 5-7 
caused a considerable reduction in yield and no 
residues beyond position 8 could be identified. 
To circumvent this problem, the chymotryptic 
peptide was digested further with thermolysin and 
the resulting peptides were separated using HPLC. 
Only two peptides, ChT I and ChT II, were 
detected; these were eluted from the column at 19 
and 25% acetonitrile, respectively. All of the 
recovered 32P radioactivity was associated with 
peptide ChT II (not shown). The amino acid com- 
positions of these two peptides are shown in table 
2. The data in tables 1 and 2 suggest hat these pep- 
tides correspond to residues 1-7 and 8-12 of the 
~hymotryptic phosphopeptide. Cleavages of 
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Table 2 
Amino acid compositions of peptides ChT I and ChT II 
Amino acid Peptide ChT I Peptide ChT II 
Asp 0.3 (0) 1.0 (1) 
Thr 1.9 (2) 0.25 (0) 
Ser _ 1.02 (1) 
Pro 1.0 (1) 
GlY 3.2 (3) 0.30 (0) 
Val 0.7 (1) _ 
Ile _ 0.85 (1) 
Leu 0.3 (0) 0.97 (1) 
Arg - 0.99 (1) 
The peptides were hydrolysed ‘with 6 N HCl for 24 h at 
110°C. Values for serine and threonine have been 
corrected for destruction by 10 and 5%, respectively. 
Values are expressed as molar ratios relative to Pro (for 
ChT I) and Asp (for ChT II). Impurities below 0.2 mol 
have been omitted 
Gly-Ile and Asn-Val bonds are in accordance 
with the known specificity of thermolysin. It is not 
clear why we did not detect another peptide (or 
peptides) corresponding to the remainder of the 
chymotryptic peptide; fluctuations in the baseline 
absorbance during the HPLC run may have been 
responsible. 
Another isolation of peptide ChT II was made 
and the peptide (10 nmol) was subjected to 
automated sequence analysis as for the second ex- 
periment described above. The first 4 amino acids 
were identified by HPLC of the Pth-derivatives as 
isoleucine, arginine, serine and leucine, respective- 
ly; the serine was detected as Pth-dehydroserine by 
absorbance measurements at 313 nm. The assign- 
ment of serine was confirmed by back hydrolysis 
and amino acid analysis, which gave alanine. 
The evidence presented here, together with the 
amino acid composition given in [7], shows that 
the sequence of the chymotryptic phosphopeptide 
derived from phosphorylated isocitrate 
dehydrogenase is Thr-Thr-Pro-Val-Gly-Gly-GIy- 
Ile-Arg-Ser(P)-Leu-Asn-Val-Ala(Asx, Glx, Glx, 
Pro, Leu, His, Lys, Tyr). 
We have recently learned that authors in [13] 
have sequenced a 7-residue tryptic phosphopeptide 
derived from the isocitrate dehydrogenase of a K12 
strain of E. coli that had been phosphorylated in 
vivo. The first 5 residues of this peptide (Ser(P)- 
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Leu-Asn-Val-Ala) are identical to residues IO-14 
of the chymotryptic peptide that we have 
sequenced. 
This is the first reported sequence round a 
phosphorylation site for a bacterial protein kinase. 
The sequence is not similar to those at sites 
phosphorylated by cyclic AMP-dependent protein 
kinase, which usually contain two basic residues on 
the amino-terminal side of the phosphorylated 
residue and separated from it by one or two in- 
tervening residues (e.g. [14]). The finding that 
isocitrate dehydrogenase cannot be 
phosphorylated by cyclic AMP-dependent protein 
kinase (unpublished) is consistent with this. One 
unusual feature of the sequence of the 
phosphopeptide from isocitrate dehydrogenase is 
the presence of one proline residue and a run of 3 
glycine residues in a 5-residue stretch on the 
amino-terminal side of the phosphorylation site. 
This region of the polypeptide is likely to form a 
flexible random coil and it may play a role in the 
enzyme/substrate recognition process. 
We have suggested that isocitrate dehydrogenase 
may be phosphorylated close to or at its NADP- 
binding site [15]. In this context it is interesting to 
note that the sequence Arg-Ser-Leu-Asn is also 
found in another NADP-binding enzyme, 
dihydrofolate reductase from chicken liver [ 161. 
This sequence, which is in the highly conserved 
amino-terminal portion of the molecule, is very 
close to the NADP-binding site [16]. We are cur- 
rently trying to identify residues at the NADP- 
binding site of isocitrate dehydrogenase so that we 
can test directly the suggestion above. 
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